GlassScriptPhysician profile
James Lloyd Thompson
NPI 1306928445
$3,069.48
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $735 · 2021: $967 · 2022: $266.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $385.07 | 2021-2022 | |
| Ucb, INC. | $357.77 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $266.04 | 2019-2022 | |
| Sk Life Science, INC. | $199.44 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $163.67 | 2019-2022 | |
| Allergan, INC. | $132.08 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $107.91 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $104.50 | 2019-2021 | |
| Biogen, INC. | $103.18 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $96.05 | 2019-2021 | |
| Emd Serono, INC. | $89.16 | 2019 | |
| Ge Healthcare | $76.53 | 2020 | |
| Csl Behring | $71.60 | 2019-2021 | |
| Akcea Therapeutics, INC. | $61.26 | 2019-2020 | |
| Grifols USA, LLC | $59.34 | 2019-2020 |
Show all 41 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.